Diabetic Foot Ulcer Market Report 2026

Diabetic Foot Ulcer Market Overview

• Diabetic Foot Ulcer market size has reached to $6.26 billion in 2025 • Expected to grow to $9.12 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Geriatric Population's Influence On The Growth Of The Diabetic Foot Ulcer Market • North America was the largest region in 2025.

What Is Covered Under Diabetic Foot Ulcer Market?

Diabetic foot ulcers are open sores or wounds that commonly develop on the feet of individuals with diabetes. These ulcers are a severe and often chronic complication of diabetes, primarily due to the adverse effects of the disease on the circulatory and nervous systems. Diabetes food ulcer treatment is used to enhance blood sugar control and vascular therapies. The main types of diabetic foot ulcers are advanced wound care dressings, biologics and therapy devices. Advanced wound care dressings refer to a category of medical dressings that are specifically designed to promote the healing of complex or chronic wounds. It includes various ulcers such as neuropathic ulcers, ischemic ulcers and neuro-ischemic ulcers. The main end-users are hospitals, ambulatory surgery centers and home care.

What Is The Diabetic Foot Ulcer Market Growth Forecast?

The diabetic foot ulcer market size is expected to see strong growth in the next few years. It will grow to $9.12 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growth in biologic wound treatments, increasing homecare adoption, technological advancements in therapy devices, rising awareness of preventive foot care, expansion of specialty wound clinics. Major trends in the forecast period include increasing adoption of advanced wound care dressings, growing use of biologics in ulcer management, rising demand for home-based wound care solutions, expansion of therapy device utilization, increased focus on early ulcer detection.

Global Diabetic Foot Ulcer Market Segmentation

1) By Type: Advanced Wound Care Dressings, Biologics, Therapy Device 2) By Ulcer Type: Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers 3) By End-User: Hospitals, Ambulatory Surgery Centers, Home Care Subsegments: 1) By Advanced Wound Care Dressings: Foam Dressings, Hydrocolloid Dressings, Alginate Dressings, Transparent Film Dressings, Antimicrobial Dressings 2) By Biologics: Skin Substitutes, Growth Factors, Human Tissue Allografts 3) By Therapy Device: Negative Pressure Wound Therapy Devices, Electrical Stimulation Devices, Hyperbaric Oxygen Therapy Devices

What Are The Drivers Of The Diabetic Foot Ulcer Market?

The rising geriatric population is expected to propel the growth of the diabetic foot ulcer market going forward. The geriatric population refers to the segment of the elderly or older, typically aged 65 and older. Diabetic foot ulcers are a common and significant concern within the senior population. Elderly individuals with diabetes are particularly susceptible to foot ulcers due to neuropathy, reduced circulation and slower healing processes. For instance, in February 2025, according to reports shared by the World Health Organization, a US-based specialized health agency, global life expectancy at birth reached 73.3 years in 2024, and the number of people aged 60 and older is projected to grow from 1.1 billion in 2023 to 1.4 billion by 2030. Therefore, the rising geriatric population is driving the growth of the diabetic foot ulcer industry. The increasing adoption of telehealth is expected to propel the growth of the diabetic foot ulcer market going forward. Telehealth refers to the delivery and facilitation of health and health-related services remotely using telecommunications technology. Telehealth services are used in diabetic foot ulcers to monitor the foot ulcer and provide follow-up care. For instance, in November 2025, according to the Australian Bureau of Statistics (ABS), an Australia-based government statistical agency, 22.5% of Australians used telehealth services in 2024–25. Among those who had a telehealth consultation, 90.3% reported they would use telehealth again if offered, up from 89.2% in 2023–24, indicating rising acceptance and continued adoption. Therefore, the increasing adoption of telehealth is driving the growth of the diabetic foot ulcer industry.

Key Players In The Global Diabetic Foot Ulcer Market

Major companies operating in the diabetic foot ulcer market are Cardinal Health Inc., Johnson And Johnson Private Limited, 3M Company, Medtronic plc, Medline Industries Inc., Coloplast A/S, B. Braun Melsungen AG, Nitto Denko Corporation, Smith and Nephew plc, Human Biosciences Inc., Derma Sciences Inc., Convatec Inc., Molnlycke Health Care AB., Integra LifeSciences Corporation, Lohmann And Rauscher International GmbH and Co. KG, Acelity L.P. Inc., Pliant Therapeutics Inc., MiMedx Group, BSN Medical GMBH, Osiris Therapeutics Inc., Advanced Medical Solutions Group plc, Organogenesis Inc., Healiance Inc., Misonix Inc., MediWound Ltd., Tissue Regenix Group Limited, Systagenix Wound Management Limited

What Are Latest Mergers And Acquisitions In The Diabetic Foot Ulcer Market?

In August 2023, Coloplast A/S, a Denmark-based medical devices company specializing in wound care, continence care, and intimate healthcare solutions, acquired Kerecis for up to USD 1.3 billion. With this acquisition, Coloplast A/S gains access to Kerecis’ patented fish-skin biologics platform, advanced wound-care technologies, and established clinical network, thereby enhancing its advanced wound-care capabilities while improving its global reach and product portfolio strength. Kerecis is an Iceland-based biotechnology company specializing in fish-skin-derived regenerative grafts for chronic and complex wound management, known for its unique intact fish-skin technology that supports natural tissue regeneration and delivers strong healing outcomes in difficult-to-treat wounds such as diabetic foot ulcers.

Regional Outlook

North America was the largest region in the diabetic foot ulcer market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diabetic Foot Ulcer Market?

The diabetic foot ulcer market consists of revenues earned by entities by providing diabetic foot ulcer services such as foot assessments, wound care, infection control, debridement, vascular assessment, nutritional support, compression therapy and blood sugar management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetic foot ulcer market also includes sales of topical antibiotics and ointments, offloading devices, special footwear, blood glucose monitors and insulin delivery devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diabetic Foot Ulcer Market Report 2026?

The diabetic foot ulcer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot ulcer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.